FI944044L - Fenylalkanolaminderivat - Google Patents
Fenylalkanolaminderivat Download PDFInfo
- Publication number
- FI944044L FI944044L FI944044A FI944044A FI944044L FI 944044 L FI944044 L FI 944044L FI 944044 A FI944044 A FI 944044A FI 944044 A FI944044 A FI 944044A FI 944044 L FI944044 L FI 944044L
- Authority
- FI
- Finland
- Prior art keywords
- phenylalkanolamine
- derivatives
- phenylalkanolamine derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Solid Fuels And Fuel-Associated Substances (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Indole Compounds (AREA)
- Table Devices Or Equipment (AREA)
- Fats And Perfumes (AREA)
- Organic Insulating Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11638593A | 1993-09-02 | 1993-09-02 | |
| US11638593 | 1993-09-02 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI944044A0 FI944044A0 (sv) | 1994-09-02 |
| FI944044L true FI944044L (sv) | 1995-03-03 |
| FI107607B FI107607B (sv) | 2001-09-14 |
Family
ID=22366865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI944044A FI107607B (sv) | 1993-09-02 | 1994-09-02 | Förfarande för framställning av terapeutiskt användbart 1,4-piperidinderivat |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP0648744B1 (sv) |
| JP (1) | JP2610784B2 (sv) |
| KR (1) | KR100360954B1 (sv) |
| CN (1) | CN1061035C (sv) |
| AT (1) | ATE162520T1 (sv) |
| AU (1) | AU7149794A (sv) |
| BR (1) | BR9403418A (sv) |
| CA (1) | CA2129771C (sv) |
| CZ (1) | CZ210694A3 (sv) |
| DE (1) | DE69408078T2 (sv) |
| DK (1) | DK0648744T3 (sv) |
| ES (1) | ES2113585T3 (sv) |
| FI (1) | FI107607B (sv) |
| GR (1) | GR3026622T3 (sv) |
| HU (1) | HUT70558A (sv) |
| IL (1) | IL110812A0 (sv) |
| NO (1) | NO943231L (sv) |
| NZ (1) | NZ264320A (sv) |
| PL (1) | PL304863A1 (sv) |
| RU (1) | RU94031753A (sv) |
| TW (1) | TW281670B (sv) |
| ZA (1) | ZA946529B (sv) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5658909A (en) * | 1994-11-17 | 1997-08-19 | Molecular Geriatrics Corporation | Certain substituted 1-aryl-3-piperazin-1'-yl propanones to treat Alzheimer's Disease |
| US6214994B1 (en) | 1997-04-21 | 2001-04-10 | Molecular Geriatrics Corporation | Certain substituted 1-aryl-3-piperazin-1′-yl propanones |
| US5693804A (en) * | 1994-11-17 | 1997-12-02 | Molecular Geriatrics Corporation | Substituted 1-aryl-3-piperazin-1'-yl propanones |
| FR2742051B1 (fr) * | 1995-12-06 | 1998-02-06 | Synthelabo | Utilisation de composes ayant une affinite pour le site de liaison du (3h)ifenprodil pour la fabrication de medicaments utiles dans la prevention et le traitement des neuropathies |
| ZA9610745B (en) * | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
| ZA9610738B (en) | 1995-12-22 | 1997-06-24 | Warner Lambert Co | Subtype selective nmda receptor ligands and the use thereof |
| ZA9610741B (en) | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
| ZA9610736B (en) * | 1995-12-22 | 1997-06-27 | Warner Lambert Co | 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists |
| TW498067B (en) * | 1996-07-19 | 2002-08-11 | Hoffmann La Roche | 4-hydroxy-piperidine derivatives |
| PL340080A1 (en) | 1997-10-24 | 2001-01-15 | Warner Lambert Co | Method of treating disease-related or post-drug dyskinesias |
| GB9804885D0 (en) | 1998-03-06 | 1998-04-29 | Merck Sharp & Dohme | Therapeutic combination |
| DE19812331A1 (de) * | 1998-03-20 | 1999-09-23 | Merck Patent Gmbh | Piperidinderivate |
| SK287726B6 (en) * | 2001-07-24 | 2011-07-06 | Richter Gedeon Vegyeszet | Carboxylic acid amide derivatives, their preparation, pharmaceutical compositions containing them and process for preparing pharmaceutical compositions |
| US7786140B2 (en) | 2003-09-25 | 2010-08-31 | Shionogi & Co., Ltd. | Piperidine derivative having NMDA receptor antagonistic activity |
| SG11201402472QA (en) | 2011-11-22 | 2014-06-27 | Univ California | Cysteamine and/or cystamine for treating ischemic injury |
| RU2649406C1 (ru) * | 2017-09-21 | 2018-04-03 | Федеральное государственное бюджетное учреждение науки Новосибирский институт органической химии им. Н.Н. Ворожцова Сибирского отделения Российской академии наук (НИОХ СО РАН) | 3-n-замещенные борнилпропионаты, используемые в качестве ингибиторов вируса марбург |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4261285A (en) * | 1984-06-01 | 1985-12-05 | Tokyo Tanabe Company Limited | 1-propanone derivatives |
| DE3433036A1 (de) * | 1984-09-08 | 1986-03-20 | Basf Ag, 6700 Ludwigshafen | Piperidinderivate und diese enthaltende fungizide sowie verfahren zur bekaempfung von pilzen |
| ES2098248T3 (es) * | 1989-05-17 | 1997-05-01 | Pfizer | Derivados de 2-piperidino-1-alcanoles como agentes antiisquemicos. |
| US4940789A (en) * | 1989-10-10 | 1990-07-10 | American Home Products Corporation | 10,11-dihydro-5-alkyl-12-substituted-10,5-(iminomethano)-5H-dibenzo[a,d]cycloheptenes as neuroprotectant agents |
| WO1992006957A1 (en) * | 1990-10-15 | 1992-04-30 | Fisons Corporation | 2-phenyl-and 2-thienyl-(2)-piperidine derivatives having neuroprotective properties |
| SE9003652D0 (sv) * | 1990-11-15 | 1990-11-15 | Astra Ab | New heterocyclic compounds |
-
1994
- 1994-08-03 TW TW083107127A patent/TW281670B/zh active
- 1994-08-09 CA CA002129771A patent/CA2129771C/en not_active Expired - Fee Related
- 1994-08-18 DE DE69408078T patent/DE69408078T2/de not_active Expired - Fee Related
- 1994-08-18 ES ES94112867T patent/ES2113585T3/es not_active Expired - Lifetime
- 1994-08-18 AT AT94112867T patent/ATE162520T1/de not_active IP Right Cessation
- 1994-08-18 EP EP94112867A patent/EP0648744B1/en not_active Expired - Lifetime
- 1994-08-18 DK DK94112867T patent/DK0648744T3/da active
- 1994-08-26 ZA ZA946529A patent/ZA946529B/xx unknown
- 1994-08-26 NZ NZ264320A patent/NZ264320A/en unknown
- 1994-08-26 AU AU71497/94A patent/AU7149794A/en not_active Abandoned
- 1994-08-29 HU HU9402479A patent/HUT70558A/hu unknown
- 1994-08-29 IL IL11081294A patent/IL110812A0/xx unknown
- 1994-08-30 JP JP6205530A patent/JP2610784B2/ja not_active Expired - Fee Related
- 1994-09-01 CN CN94115651A patent/CN1061035C/zh not_active Expired - Fee Related
- 1994-09-01 RU RU94031753/04A patent/RU94031753A/ru unknown
- 1994-09-01 NO NO943231A patent/NO943231L/no unknown
- 1994-09-01 PL PL94304863A patent/PL304863A1/xx unknown
- 1994-09-01 KR KR1019940021962A patent/KR100360954B1/ko not_active Expired - Fee Related
- 1994-09-01 CZ CZ942106A patent/CZ210694A3/cs unknown
- 1994-09-01 BR BR9403418A patent/BR9403418A/pt not_active Application Discontinuation
- 1994-09-02 FI FI944044A patent/FI107607B/sv active
-
1998
- 1998-04-10 GR GR980400818T patent/GR3026622T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL110812A0 (en) | 1994-11-11 |
| RU94031753A (ru) | 1996-07-20 |
| GR3026622T3 (en) | 1998-07-31 |
| FI944044A0 (sv) | 1994-09-02 |
| NO943231D0 (no) | 1994-09-01 |
| KR950008481A (ko) | 1995-04-17 |
| JP2610784B2 (ja) | 1997-05-14 |
| DE69408078T2 (de) | 1998-07-09 |
| FI107607B (sv) | 2001-09-14 |
| CZ210694A3 (en) | 1995-08-16 |
| CA2129771C (en) | 2006-03-21 |
| NZ264320A (en) | 1996-02-27 |
| CN1061035C (zh) | 2001-01-24 |
| BR9403418A (pt) | 1996-09-03 |
| NO943231L (no) | 1995-03-03 |
| CN1105990A (zh) | 1995-08-02 |
| AU7149794A (en) | 1995-03-16 |
| ZA946529B (en) | 1995-03-02 |
| EP0648744B1 (en) | 1998-01-21 |
| ATE162520T1 (de) | 1998-02-15 |
| CA2129771A1 (en) | 1995-03-03 |
| KR100360954B1 (ko) | 2003-04-16 |
| EP0648744A1 (en) | 1995-04-19 |
| HUT70558A (en) | 1995-10-30 |
| TW281670B (sv) | 1996-07-21 |
| ES2113585T3 (es) | 1998-05-01 |
| PL304863A1 (en) | 1995-03-06 |
| HU9402479D0 (en) | 1994-10-28 |
| JPH0782250A (ja) | 1995-03-28 |
| DK0648744T3 (da) | 1998-09-21 |
| DE69408078D1 (de) | 1998-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI943976A7 (sv) | 5-arylindolderivat | |
| FI930208L (fi) | Kinazolinderivat | |
| FI935431A7 (sv) | Kinazolinderivat | |
| FI980341L (sv) | 2-oxindolderivat | |
| ATA75293A (de) | Indolderivate | |
| FI933037A7 (fi) | Tiazolylvinylfenylderivat | |
| FI941423A7 (sv) | 17beta-substituerade 4-aza-5alfa-androstan-3-onderivat | |
| FI945674A7 (sv) | Substituerade 2beta-morfolin-androstanderivat | |
| DE69330497D1 (de) | Chinazolin-derivate | |
| FI20010214L (sv) | Acylaminoindolderivat | |
| FI942444A7 (sv) | Tetrahydropyranderivat | |
| FI943885L (sv) | Penamderivat | |
| DE59308714D1 (de) | Cyclobutan-benzol-derivate | |
| FI20002460A7 (sv) | 4-difenylmetylpiperidinderivat | |
| FI944044L (sv) | Fenylalkanolaminderivat | |
| ATA146094A (de) | Windsichter | |
| NO952288D0 (no) | Benzazepinon-derivater | |
| DE69313890D1 (de) | 5-Aminoflavon-Derivate | |
| FI930367L (fi) | Puridinderivat | |
| ATA212793A (de) | Sportschuh | |
| ATA194593A (de) | Sportschuh | |
| DE59407726D1 (de) | 3-Aryl-4-hydroxy-3-dihydrofuranon-Derivate | |
| FI930873A7 (fi) | Tetrahydrotiofenderivat | |
| FI930934L (fi) | Tetrahydropyrimidinderivat | |
| FI930922A7 (fi) | Substituerade fenylkinazolinderivat |